DVSMX

Driehaus Small Cap Growth Investor
NasdaqUSDETF / FUND DELAYED
Last price
28.50
▼ 0.53 (1.83%)
MARKET · —

Price

1D — H — L — Range — Vol —
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
29.03
Day high
—
Day low
—
Volume
—
Market cap
—
P/E (TTM)
—
52W range
24.53 – 33.35

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
+0.18% -1.8%
1M
-4.94% -6.4%
3M
-11.41% -14.8%
6M
+5.44% -9.6%
YTD
+6.86% -7.2%
1Y
+10.08% -5.7%
3Y
+70.56% -11.4%
5Y
— —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Top holdings

10 shown · by weight
SymbolNameWeight
BGSXX Northern Institutional US Govt Sel 2.63%
GH Guardant Health Inc 2.40%
SYRE Spyre Therapeutics Inc 2.11%
CRNX Crinetics Pharmaceuticals Inc 1.83%
PRAX Praxis Precision Medicines Inc Ordinary Shares 1.80%
DFTX Definium Therapeutics Inc Ordinary Shares 1.79%
XENE Xenon Pharmaceuticals Inc 1.61%
CW Curtiss-Wright Corp 1.59%
EWTX Edgewise Therapeutics Inc 1.39%
TWST Twist Bioscience Corp 1.37%

Sector exposure

Fund weightings
Healthcare
32.13%
Industrials
18.88%
Technology
17.72%
Consumer cyclical
14.50%
Financial services
8.64%
Consumer defensive
2.55%
Energy
2.11%
Basic materials
1.37%
Communication services
0.94%
Real estate
0.66%
Utilities
0.50%

Fund profile

As reported
Fund familyDriehaus
CategorySmall Growth
Legal type—
Expense ratio0.93%
Turnover—
Total net assets—

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Free account

5 more panels on DVSMX open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Fundamentals

TTM · reported
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—

Valuation & profitability ratios

Account required
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Options analytics

Account required
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Analyst targets & ownership

Account required
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
28.63
-0.44% from price
SMA 20
28.83
-1.15% from price
SMA 50
30.01
-5.03% from price
SMA 100
30.80
-7.48% from price
SMA 200
29.61
-3.75% from price
EMA 12
28.78
-0.96% from price
EMA 26
29.18
-2.33% from price
EMA 50
29.74
-4.17% from price
RSI (14)
38.2
Neutral
MACD (12,26,9)
-0.40
Hist 0.07
ATR (14)
0.21
0.72% of price
Realised vol 30D
16.1%
Annualised
Bollinger upper
29.41
20, 2σ
Bollinger lower
28.25
20, 2σ
50 / 200 cross
Golden
30.01 vs 29.61
Trend bias
Below 200
-3.75%

Options chain

Account required
Expiry
Spot 28.50
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
-0.03
Less volatile than market
Correlation to SPY
-0.02
Largely independent
Realised vol 30D
16.1%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-15.4%
Peak to trough
Max drawdown 5Y
-53.8%
Peak to trough
ATR 14
0.21
0.72% of price
Beta (reported)
—
5Y monthly, from filing

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.